PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1811, Issue 2, 2011, Pages 59-67

  Álvarez Guardia, David ^a   Palomer, Xavier ^a   Coll, Teresa ^a   Serrano, Lucía ^a   Rodríguez Calvo, Ricardo ^a   Davidson, Mercy M ^b   Merlos, Manuel ^a   El Kochairi, Ilhem ^c   Michalik, Liliane ^c   Wahli, Walter ^c   Vázquez Carrera, Manuel ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Heart; High fat diet; Inflammation; NF B; Nuclear factor B; Peroxisome proliferator activated receptor

Indexed keywords

[2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPID; MONOCYTE CHEMOTACTIC PROTEIN 1; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDITIS; CONTROLLED STUDY; FAT CONTENT; HEART HYPERTROPHY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INFLAMMATION; LIPID DIET; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSACTIVATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; CELLS, CULTURED; DIETARY FATS; HEART; HUMANS; INFLAMMATION; LIPIDS; MICE; MICE, KNOCKOUT; MYOCARDIUM; PPAR DELTA; PPAR-BETA; SIGNAL TRANSDUCTION; THIAZOLES; TRANSCRIPTION FACTOR RELA;

MUS;

EID: 78650605981     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2010.11.002     Document Type: Article

References (39)

1. C. Ancey, E. Menet, P. Corbi, S. Fredj, M. Garcia, C. Rucker-Martin, J. Bescond, F. Morel, J. Wijdenes, J.C. Lecron, and D. Potreau Human cardiomyocyte hypertrophy induced in vitro by gp130 stimulation Cardiovasc. Res. 59 2003 78 85
2. G. Ding, L. Cheng, Q. Qin, S. Frontin, and Q. Yang PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes J. Mol. Cell. Cardiol. 40 2006 821 828
3. H. Takano, T. Nagai, M. Asakawa, T. Toyozaki, T. Oka, I. Komuro, T. Saito, and Y. Masuda Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes Circ. Res. 87 2000 596 602
4. W.K. Jones, M. Brown, X. Ren, S. He, and M. McGuinness NF-kappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling? Cardiovasc. Toxicol. 3 2003 229 254
5. C. Tikellis, M.C. Thomas, B. Harcourt, M.T. Coughlan, J. Pete, K. Bialkowski, A. Tan, A. Bierhaus, M.E. Cooper, and J.M. Forbes Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs Am. J. Physiol. Endocrinol. Metab. 295 2008 E323 E330
6. M.N. Sack, T.A. Rader, S. Park, J. Bastin, S.A. McCune, and D.P. Kelly Fatty acid oxidation enzyme gene expression is downregulated in the failing heart Circulation 94 1996 2837 2842
7. A. Planavila, R. Rodríguez-Calvo, M. Jove, L. Michalik, W. Wahli, J.C. Laguna, and M. Vázquez-Carrera Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes Cardiovasc. Res. 65 2005 832 841
8. R.A. Daynes, and D.C. Jones Emerging roles of PPARs in inflammation and immunity Nat. Rev. Immunol. 2 2002 748 759
9. A. Planavila, J.C. Laguna, and M. Vázquez-Carrera Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy J. Biol. Chem. 280 2005 17464 17471
10. M.J. Raher, H.B. Thibault, E.S. Buys, D. Kuruppu, N. Shimizu, A.L. Brownell, S.L. Blake, J. Rieusset, M. Kaneki, G. Derumeaux, M.H. Picard, K.D. Bloch, and M. Scherrer-Crosbie A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overload Am. J. Physiol. Heart Circ. Physiol. 295 2008 H2495 H2502
11. C.N. Palmer, M.H. Hsu, K.J. Griffin, J.L. Raucy, and E.F. Johnson Peroxisome proliferator activated receptor-alpha expression in human liver Mol. Pharmacol. 53 1998 14 22
12. J.W. Lawrence, Y. Li, S. Chen, J.G. DeLuca, J.P. Berger, D.R. Umbenhauer, D.E. Moller, and G. Zhou Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expression J. Biol. Chem. 276 2001 31521 31527
13. X. Palomer, D. Álvarez-Guardia, R. Rodriguez-Calvo, T. Coll, J.C. Laguna, M.M. Davidson, T.O. Chan, A.M. Feldman, and M. Vazquez-Carrera TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model Cardiovasc. Res. 81 2009 703 712
14. T. Coll, X. Palomer, F. Blanco-Vaca, J.C. Escola-Gil, R.M. Sanchez, J.C. Laguna, and M. Vazquez-Carrera Cyclooxygenase 2 inhibition exacerbates palmitate-induced inflammation and insulin resistance in skeletal muscle cells Endocrinology 151 2010 537 548
15. K. Nadra, S.I. Anghel, E. Joye, N.S. Tan, S. Basu-Modak, D. Trono, W. Wahli, and B. Desvergne Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/delta Mol. Cell. Biol. 26 2006 3266 3281
16. B.G. Shearer, D.J. Steger, J.M. Way, T.B. Stanley, D.C. Lobe, D.A. Grillot, M.A. Iannone, M.A. Lazar, T.M. Willson, and A.N. Billin Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist Mol. Endocrinol. 22 2008 523 529
17. N. Suematsu, H. Tsutsui, J. Wen, D. Kang, M. Ikeuchi, T. Ide, S. Hayashidani, T. Shiomi, T. Kubota, N. Hamasaki, and A. Takeshita Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes Circulation 107 2003 1418 1423
18. M. Sano, K. Fukuda, T. Sato, H. Kawaguchi, M. Suematsu, S. Matsuda, S. Koyasu, H. Matsui, K. Yamauchi-Takihara, M. Harada, Y. Saito, and S. Ogawa ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts Circ. Res. 89 2001 661 669
19. P. Delerive, J.C. Fruchart, and B. Staels Peroxisome proliferator- activated receptors in inflammation control J. Endocrinol. 169 2001 453 459
20. P. Delerive, K. De Bosscher, S. Besnard, W. Vanden Berghe, J.M. Peters, F.J. González, J.C. Fruchart, A. Tedgui, G. Haegeman, and B. Staels Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1 J. Biol. Chem. 274 1999 32048 32054
21. D.K. Kramer, L. Al Khalili, B. Guigas, Y. Leng, P.M. Garcia-Roves, and A. Krook Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle J. Biol. Chem. 282 2007 19313 19320
22. H.L. Li, R. Yin, D. Chen, D. Liu, D. Wang, Q. Yang, and Y.G. Dong Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy J. Cell. Biochem. 100 2007 1086 1099
23. H.J. Ko, Z. Zhang, D.Y. Jung, J.Y. Jun, Z. Ma, K.E. Jones, S.Y. Chan, and J.K. Kim Nutrient stress activates inflammation and reduces glucose metabolism by Suppressing AMPK in heart Diabetes 58 2009 2536 2546
24. B.L. Bernardo, T.S. Wachtmann, P.G. Cosgrove, M. Kuhn, A.C. Opsahl, K.M. Judkins, T.B. Freeman, J.R. Hadcock, and N.K. LeBrasseur Postnatal PPARdelta activation and myostatin inhibition exert distinct yet complimentary effects on the metabolic profile of obese insulin-resistant mice PLoS ONE 5 2010 e11307
25. J. Molnar, S. Yu, N. Mzhavia, C. Pau, I. Chereshnev, and H.M. Dansky Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed C57BL/6J mice Circ. Res. 96 2005 1178 1184
26. C. Weigert, K. Brodbeck, H. Staiger, C. Kausch, F. Machicao, H.U. Haring, and E.D. Schleicher Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB J. Biol. Chem. 279 2004 23942 23952
27. E. Haugen, J. Chen, J. Wikstrom, J. Gronros, L.M. Gan, and L.X. Fu Parallel gene expressions of IL-6 and BNP during cardiac hypertrophy complicated with diastolic dysfunction in spontaneously hypertensive rats Int. J. Cardiol. 115 2007 24 28
28. P.J. Smeets, B.E. Teunissen, A. Planavila, H. de Vogel-van den Bosch, P.H. Willemsen, G.J. van der Vusse, and M. van Bilsen Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by PPARalpha and PPARdelta J. Biol. Chem. 283 2008 29109 29118
29. T. Coll, E. Eyre, R. Rodriguez-Calvo, X. Palomer, R. Sánchez, M. Merlos, J.C. Laguna, and M. Vázquez-Carrera Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells J. Biol. Chem. 283 2008 11107 11116
30. T. Coll, M. Jove, R. Rodriguez-Calvo, E. Eyre, X. Palomer, R.M. Sánchez, M. Merlos, J.C. Laguna, and M. Vázquez-Carrera Palmitate-mediated downregulation of peroxisome proliferator receptor γ coactivator 1α (PGC-1α) in skeletal muscle cells involves MEK1/2 and NF-κB activation Diabetes 55 2006 2779 2787
31. A. Kadotani, Y. Tsuchiya, H. Hatakeyama, H. Katagiri, and M. Kanzaki Different impacts of saturated and unsaturated free fatty acids on COX-2 expression in C(2)C(12) myotubes Am. J. Physiol. Endocrinol. Metab. 297 2009 E1291 E1303
32. W.R. Oliver Jr., J.L. Shenk, M.R. Snaith, C.S. Russell, K.D. Plunket, N.L. Bodkin, M.C. Lewis, D.A. Winegar, M.L. Sznaidman, M.H. Lambert, H.E. Xu, D.D. Sternbach, S.A. Kliewer, B.C. Hansen, and T.M. Willson A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport Proc. Natl Acad. Sci. USA 98 2001 5306 5311
33. T. Kino, K.C. Rice, and G.P. Chrousos The PPARdelta agonist GW501516 suppresses interleukin-6-mediated hepatocyte acute phase reaction via STAT3 inhibition Eur. J. Clin. Invest. 37 2007 425 433
34. B.N. Finck The PPAR regulatory system in cardiac physiology and disease Cardiovasc. Res. 73 2007 269 277
35. K. Boengler, D. Hilfiker-Kleiner, H. Drexler, G. Heusch, and R. Schulz The myocardial JAK/STAT pathway: from protection to failure Pharmacol. Ther. 120 2008 172 185
36. P.D. Cani, J. Amar, M.A. Iglesias, M. Poggi, C. Knauf, D. Bastelica, A.M. Neyrinck, F. Fava, K.M. Tuohy, C. Chabo, A. Waget, E. Delmee, B. Cousin, T. Sulpice, B. Chamontin, J. Ferrieres, J.F. Tanti, G.R. Gibson, L. Casteilla, N.M. Delzenne, M.C. Alessi, and R. Burcelin Metabolic endotoxemia initiates obesity and insulin resistance Diabetes 56 2007 1761 1772
37. Y. Zhou, C. Yau, J.W. Gray, K. Chew, S.H. Dairkee, D.H. Moore, U. Eppenberger, S. Eppenberger-Castori, and C.C. Benz Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer BMC Cancer 7 2007 59
38. R. Rodriguez-Calvo, L. Serrano, T. Coll, N. Moullan, R.M. Sanchez, M. Merlos, X. Palomer, J.C. Laguna, L. Michalik, W. Wahli, and M. Vazquez-Carrera Activation of peroxisome proliferator-activated receptor beta}/{delta (PPAR{beta}/{delta}) inhibits LPS-induced cytokine production in adipocytes by lowering NF-{kappa}B activity via ERK1/2 Diabetes 57 2008 2149 2157
39. K.D. Wagner, and N. Wagner Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions Pharmacol. Ther. 125 2010 423 435